Skip to main content

Annovis Bio, Inc.

ANVS
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001477845

No open-market purchases or sales by Annovis Bio, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $20.2M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Annovis Bio, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
32
−6 vs. Q3 2021
Shares held
1.12M
−24.6K (−2.2%) vs. Q3 2021
Total value
$19.6M
−$16.6M (−45.8%) vs. Q3 2021
New holders
8
8 more added
Sold out
14
9 more reduced

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ANVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 32 institutions
Q1 2021: 31 institutionsQ2 2021: 57 institutionsQ3 2021: 38 institutionsQ4 2021: 32 institutionsQ1 2022: 24 institutionsQ2 2022: 26 institutionsQ3 2022: 25 institutionsQ4 2022: 23 institutionsQ1 2023: 23 institutionsQ2 2023: 28 institutionsQ3 2023: 30 institutionsQ4 2023: 36 institutionsQ1 2024: 31 institutionsQ2 2024: 31 institutionsQ3 2024: 35 institutionsQ4 2024: 40 institutionsQ1 2025: 44 institutionsQ2 2025: 42 institutionsQ3 2025: 42 institutionsQ4 2025: 53 institutionsQ1 2026: 56 institutionsQ2 2026: 61 institutions
Value heldQ4 2021: $19.6M
Q1 2021: $23.1MQ2 2021: $109.0MQ3 2021: $36.2MQ4 2021: $19.6MQ1 2022: $11.9MQ2 2022: $8.73MQ3 2022: $10.0MQ4 2022: $9.93MQ1 2023: $11.6MQ2 2023: $18.3MQ3 2023: $10.6MQ4 2023: $22.5MQ1 2024: $14.3MQ2 2024: $5.67MQ3 2024: $9.50MQ4 2024: $7.93MQ1 2025: $3.13MQ2 2025: $3.93MQ3 2025: $4.19MQ4 2025: $14.7MQ1 2026: $10.5MQ2 2026: $20.2M
Institutions holding ANVS and their total value by quarter
QuarterHoldersValue
Q2 202661$20.2M
Q1 202656$10.5M
Q4 202553$14.7M
Q3 202542$4.19M
Q2 202542$3.93M
Q1 202544$3.13M
Q4 202440$7.93M
Q3 202435$9.50M
Q2 202431$5.67M
Q1 202431$14.3M
Q4 202336$22.5M
Q3 202330$10.6M
Q2 202328$18.3M
Q1 202323$11.6M
Q4 202223$9.93M
Q3 202225$10.0M
Q2 202226$8.73M
Q1 202224$11.9M
Q4 202132$19.6M
Q3 202138$36.2M
Q2 202157$109.0M
Q1 202131$23.1M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Annovis Bio, Inc.; share changes are against Q3 2021.

Institutions holding ANVS in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc229,155$4.03M0.00%−329−0.1%Reduced
Morgan Stanley154,981$2.72M0.00%+117,015+308.2%Added
BlackRock Inc.147,599$2.60M0.00%+44,269+42.8%Added
Millennium Management LLC67,144$1.18M0.00%+1,525+2.3%Added
Two Sigma Advisers, LP63,800$1.12M0.00%+33,600+111.3%Added
Citadel Advisors LLC59,147$1.04M0.00%+21,925+58.9%Added
Two Sigma Investments, LP51,747$910.0K0.00%−45,819−47.0%Reduced
Wescott Financial Advisory Group, LLC41,607$731.0K0.38%00.0%Unchanged
Geode Capital Management, LLC40,945$719.0K0.00%00.0%Unchanged
Modera Wealth Management, LLC32,313$568.0K0.02%−985−3.0%Reduced
Bank of New York Mellon Corp30,903$543.0K0.00%+4,867+18.7%Added
Bridgeway Capital Management, LLC23,600$415.0K0.01%00.0%Unchanged
Voloridge Investment Management, LLC23,116$406.0K0.00%−85,622−78.7%Reduced
Blueshift Asset Management, LLC16,418$289.0K0.03%+16,418New
State Street Corp16,400$288.0K0.00%00.0%Unchanged
Sterling Investment Advisors, Ltd.14,474$254.0K0.07%00.0%Unchanged
Knoll Capital Management, LLC14,210$250.0K0.14%00.0%Unchanged
Bank of America Corp12,151$214.0K0.00%−5,327−30.5%Reduced
Cubist Systematic Strategies, LLC11,743$206.0K0.00%+11,743New
Essex LLC10,593$186.0K0.05%−1,369−11.4%Reduced
Renaissance Technologies LLC10,500$185.0K0.00%+10,500New
Goldman Sachs Group Inc10,273$181.0K0.00%+10,273New
Cannell Peter B & Co Inc10,000$176.0K0.00%−6,200−38.3%Reduced
Wells Fargo & Company8,777$155.0K0.00%−1,000−10.2%Reduced
Advisor Group Holdings, Inc.8,594$152.0K0.00%−2,408−21.9%Reduced
UBS Group AG2,481$44.0K0.00%+2,088+531.3%Added
Marshall Wace, LLP1,679$29.0K0.00%+1,679New
Rockefeller Capital Management L.P.1,000$17.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)669$12.0K0.00%+442+194.7%Added
Citigroup Inc5$00.00%+5New
Royal Bank of Canada3$00.00%+3New
Financial Connections Group, Inc.25$00.00%+25New
AIGH Capital Management LLC0$00.00%−66,469−100.0%Sold out
Worth Venture Partners, LLC0$00.00%−19,878−100.0%Sold out
Virtu Financial LLC0$00.00%−11,547−100.0%Sold out
Bank of Montreal0$00.00%−9,500−100.0%Sold out
Bryn Mawr Trust Co0$00.00%−9,393−100.0%Sold out
Northern Trust Corp0$00.00%−9,098−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−7,908−100.0%Sold out
Redmond Asset Management, LLC0$00.00%−7,878−100.0%Sold out
Wealthspire Advisors, LLC0$00.00%−7,500−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−2,387−100.0%Sold out
Spire Wealth Management0$00.00%−310−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−32−100.0%Sold out
Harbour Investments, Inc.0$00.00%−6−100.0%Sold out
McCarthy Asset Management, Inc.0$00.00%−15−100.0%Sold out